NIKI

Niki BioSolutions Inc.

NIKI | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.77

-$0.19 (-9.51%)

At close: Oct 30, 2026, 4:00 PM ET

$1.70

-$0.07 (-3.95%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-9.51%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

+2.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #1006/1028 (Top 98%)

Full Analysis

Key Statistics

Market Data

Market Cap $144.14K

1D Range

1.70 1.93

52W Range

1.70 10.17

Valuation (TTM)

PE -0.09

PB 0.01

EV/EBITDA -0.07

Valuation (NTM)

Forward PE 0.36

Forward PEG -0.00

Price Target $0.00

Cash Flow

FCF Yield -371.3%

SBC Adj. FCF Yield -371.3%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -150.0% | -67.0%

Dil EPS 3Y | 5Y 133.1% | 69.2%

FCF 3Y | 5Y 80.8% | 48.9%

Returns

ROA -7.3%

ROE -5.9%

ROIC -2.3%

Financial Health

Net Cash

$34.39K

Current Ratio 0.78

Interest Coverage -5.48

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of the...

Sector Healthcare

Industry Biotechnology

Employees 1

IPO Date Jul 20, 2026

Website www.aptorumgroup.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.